ArticleNucleic acids research2025
Design of orthogonal and portable RNA devices for post-transcriptional regulation by reverse engineering type I toxin-antitoxin systems.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Engineering a heme-dependent tryptophan hydroxylase pathway inSynthetic and systems biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Type I toxin-antitoxin (TA) systems are widely distributed in the prokaryotic world, known for their antitoxin RNA interfering with the cognate toxin mRNA translation. Beyond their canonical role in plasmid maintenance, these systems represent evolutionarily optimized regulatory modules with rapid kinetics and modular architectures. Here, we repurposed them as post-transcriptional regulatory RNA devices via reverse engineering. After isolating the core of type I TA pairs and demonstrating the independence between their structure and repression function, we reconstructed artificial TA pairs termed SRTS-OPRTS. A platform for generating orthogonal SRTS-OPRTS pairs with cross-species application (Bacillus subtilis, Escherichia coli, and Corynebacterium glutamicum) was developed by introducing structure and energy constraints. As an individual expressing element or a co-expressing 3' UTR tag within specific mRNA, SRTS achieved quantitative regulation of the gene with 3' UTR cognate OPRTS. Such portability enabled convenient construction of dynamic mutually inhibitory switches, where genes tagged by SRTS and OPRTS could regulate each other. Leveraging this approach, a selective lethal system was further constructed to enrich high-fluorescent mutants, resulting in up to 11.32-fold enhancement in mean fluorescence intensity. Overall, these synthetic RNA devices provide portable tools for gene regulation and offer a robust foundation for constructing dynamic genetic circuits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.